Development and Application of a Nurse-Led Preemptive Symptom Management Protocol for Head and Neck Cancer Patients Undergoing Radiation Therapy

Recruiting now · Phase 3

Conditions studied: Head and Neck Cancer

In brief

The aim of this study is to investigate whether a nurse-led preemptive symptom management protocol can reduce the radiation therapy interruption rate in patients with head and neck cancer compared to conventional care models.

Key facts

Study ID

NCT07467083

Run by

West China Hospital

People needed

170

Starts

2026-03-15

Expected to finish

2027-03-01

Last updated by the study team

2026-04-01

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients had pathologically confirmed malignant head and neck tumors without distant metastasis.
• Patient age ≥18 years; Patients were scheduled to undergo either postoperative adjuvant radiotherapy or radical radiotherapy, with or without concurrent chemotherapy.
• Baseline ECOG (Eastern Cooperative Oncology Group) score 0-2;
• Good cognitive and reading skills, able to complete the questionnaire survey.

You may not qualify if…

• Presence of other malignant tumors aside from head and neck malignancies;
• A history of prior head and neck radiotherapy;
• Mental illness or cognitive impairments;
• Uncontrolled systemic diseases that could significantly affect their QoL.

Where it is running

• West China Hospital of Sichuan University — Chengdu, Sichuan, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.